RoundTable Healthcare Partners Completes Acquisition of Advantis Medical, Inc.
LAKE FOREST, Ill. -- RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has
completed the acquisition of Advantis Medical, Inc. Advantis is a leading designer and manufacturer of medical case / tray organizing systems for surgical instruments, implants and medical devices. Advantis will be combined with Instrumed International, Inc.
RoundTable acquired a majority interest in Instrumed in October 2005. Instrumed specializes in the manufacturing and sourcing of premium quality surgical instruments. The two companies will form a new medical device outsourcing platform operating under the name Avalign Technologies, Inc. The financial terms of the transaction and RoundTable's investment were not disclosed.
"We are excited about the combination of Advantis and Instrumed to form Avalign," said Joseph F. Damico, a founding partner of RoundTable and new chairman of Avalign. "We are impressed with Advantis' design and engineering capabilities and its strong commitment to quality and customer service. These core competencies, combined with Instrumed's expertise in manufacturing and sourcing precision surgical instruments, will position Avalign as a leading full-service provider of outsourced services to medical device OEM customers."
With the formation of Avalign, RoundTable also announced that Forrest R. Whittaker has joined as Avalign's new CEO. Whittaker has more than 30 years of healthcare experience, previously serving as the president and COO of Teleflex Medical and in various senior executive roles at Tyco Healthcare, Baxter Healthcare and American Hospital Supply.
As part of the transaction and to finance further growth opportunities for Avalign, RoundTable facilitated the successful completion of new senior credit facilities and a private placement of subordinated notes. The senior credit facilities were led by LaSalle Bank and GE Healthcare Financial Services also participated in the transaction. Avalign's senior subordinated notes were purchased by RoundTable Capital Partners, RoundTable's $200 million captive subordinated debt fund.
Source: RoundTable Healthcare Partners
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
